Summary of opinion: Suvaxyn PRRS MLV, 19/06/2024 Positive
On 19 June 2024, the Committee for Veterinary Medicinal Products (CVMP) adopted a positive opinion1, recommending the granting of a group of variations to the terms of the marketing authorisation for the veterinary medicinal product Suvaxyn PRRS MLV. The …